These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17312156)

  • 1. Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses.
    Thomas PG; Brown SA; Keating R; Yue W; Morris MY; So J; Webby RJ; Doherty PC
    J Immunol; 2007 Mar; 178(5):3091-8. PubMed ID: 17312156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting.
    Jenkins MR; Webby R; Doherty PC; Turner SJ
    J Immunol; 2006 Sep; 177(5):2917-25. PubMed ID: 16920927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses.
    Andreansky SS; Stambas J; Thomas PG; Xie W; Webby RJ; Doherty PC
    J Virol; 2005 Apr; 79(7):4329-39. PubMed ID: 15767433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice.
    Tan AC; La Gruta NL; Zeng W; Jackson DC
    J Immunol; 2011 Aug; 187(4):1895-902. PubMed ID: 21765016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and compensation in the influenza virus-specific CD8+ T cell response.
    Webby RJ; Andreansky S; Stambas J; Rehg JE; Webster RG; Doherty PC; Turner SJ
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7235-40. PubMed ID: 12775762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple distinct forms of CD8+ T cell cross-reactivity and specificities revealed after 2009 H1N1 influenza A virus infection in mice.
    Guo H; Topham DJ
    PLoS One; 2012; 7(9):e46166. PubMed ID: 23029425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of suboptimal priming are apparent for low-avidity T-cell responses.
    Venturi V; Davenport MP; Swan NG; Doherty PC; Kedzierska K
    Immunol Cell Biol; 2012 Feb; 90(2):216-23. PubMed ID: 21556018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells.
    Day EB; Zeng W; Doherty PC; Jackson DC; Kedzierska K; Turner SJ
    J Immunol; 2007 Aug; 179(4):2187-94. PubMed ID: 17675478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.
    Belz GT; Xie W; Altman JD; Doherty PC
    J Virol; 2000 Apr; 74(8):3486-93. PubMed ID: 10729122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.
    Machkovech HM; Bedford T; Suchard MA; Bloom JD
    J Virol; 2015 Nov; 89(22):11275-83. PubMed ID: 26311880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.
    Bodewes R; Geelhoed-Mieras MM; Nieuwkoop NJ; Hanson JA; David CS; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Virus Res; 2011 Jan; 155(1):123-30. PubMed ID: 20863862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function.
    Day EB; Charlton KL; La Gruta NL; Doherty PC; Turner SJ
    J Immunol; 2011 Jun; 186(11):6319-28. PubMed ID: 21536802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.
    Akram A; Inman RD
    Eur J Immunol; 2013 Dec; 43(12):3254-67. PubMed ID: 24113999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.
    Crowe SR; Miller SC; Shenyo RM; Woodland DL
    J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
    Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
    J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
    Cheuk E; Chamberlain JW
    Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal deoxynucleotidyltransferase is required for the establishment of private virus-specific CD8+ TCR repertoires and facilitates optimal CTL responses.
    Kedzierska K; Thomas PG; Venturi V; Davenport MP; Doherty PC; Turner SJ; La Gruta NL
    J Immunol; 2008 Aug; 181(4):2556-62. PubMed ID: 18684946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.
    Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC
    Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homogenization of TCR repertoires within secondary CD62Lhigh and CD62Llow virus-specific CD8+ T cell populations.
    Kedzierska K; Venturi V; Valkenburg SA; Davenport MP; Turner SJ; Doherty PC
    J Immunol; 2008 Jun; 180(12):7938-47. PubMed ID: 18523257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
    Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.